Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
In this episode of
Industry Focus: Consumer Goods, Motley Fool contributor and cannabis expert Keith Speights joins host Emily Flippen as they celebrate April 20 by talking about how investors should (and shouldn t) get invested in marijuana, as well as some of their favorite ideas for all types of investors.
To catch full episodes of all The Motley Fool s free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
XS Financial Announces 11th Drawdown by Ayr Wellness
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
XS Financial Announces 11th Drawdown by Ayr Wellness
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
XS Financial Announces 11th Drawdown by Ayr Wellness
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Horizons ETFs Made Waves When They Launched the World’s First Psychedelics Stock ETF on the NEO Exchange Early This Year
The Dales Report sat down with Steve Hawkins, the President and CEO of Horizons ETFs for an interview, to learn a little bit more about the behind-the-scenes on creating a Psychedelics ETF like
Horizons Psychedelic Stock Index ETF (NEO: PSYK) from scratch, what investors should know, and where the Psychedelics industry – and others – might be headed. Right now, Hawkings says, the psychedelics industry resembles Cannabis in capital market structure. There’s very few companies in the space, but with big IPOs, and multiple U.S. companies that are looking at moving into Canadian space.